Screening Libraries

Small molecule screening libraries
for high-throughput screening
and fragment-based screening

Chemical Building Blocks

Specialty chemical building blocks
for hit-to-lead, lead optimization,
and medicinal chemistry programs

Chemistry Services

Synthetic chemistry services including
custom synthesis, medchem support
and exclusive library synthesis

Online Chemical Store

Search our complete inventory of
screening compounds & building blocks
and view up-to-date pricing & availability

New Macrocycle Library Released

ChemBridge has released it's new Macrocycle Library of more than 6,000 macrocyclic screening compounds. To date we have developed over 70 core macrocyclic scaffolds. Primary ring sizes range from 11 to 27 atoms and MW weight up to 800. For more details on this new library, please click here.

Join ChemBridge at ASMC2017 in Vienna, Austria

The 7th International Symposium on Advances in Synthetic and Medicinal Chemistry will be held August 27 to 31 in Vienna, Austria. ChemBridge is pleased to be a co-organizer along with the European Federation of Medicinal Chemistry. James Bradner, President of the Novartis Institutes for BioMedical Research (NIBR), Cambridge, MA, will give the opening lecture. ASMC2017 is the 7th edition of the symposium originally started by ChemBridge in Moscow in 2004, followed by later editions in St. Petersburg in 2007 and 2011, Kiev in 2009, Moscow in 2013, and Rehovot, Israel in 2015. Click here to visit the symposium website.

About ChemBridge

ChemBridge Corporation is a global provider of enabling chemistry products and contract research services for small molecule drug discovery. ChemBridge’s extensive portfolio includes over 1.1 million diverse and target-focused screening compounds, over 14,000 chemical building blocks, our Hit2Lead.com on-line chemical store, and high-end, research-intensive custom library and synthetic/medicinal chemistry services...(read more)


Corporate Profile